Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Cloud Peter Paweletz

机构:Harvard University, Dana-Farber Cancer Institute · ORCID:0000-0002-2287-5663

发表论文 760 篇 · 总被引 23171 次 · h-index 73

代表论文

  • Vascular STING activation facilitates NK cell anti-tumor immunity in small cell lung cancer (2026 · Cancer Cell · 被引 12)
  • EGFR-mutant transformed small cell lung cancer harbors intratumoral heterogeneity targetable with MEK inhibitor combination therapy (2026 · JCI Insight · 被引 4)
  • Drug-tolerant persisters and immunotherapy persister cells exhibit cross-resistance and share common survival mechanisms (2025 · Cell Death and Differentiation · 被引 4)
  • ESR1 mutations and CDK4/6 inhibitor choice shape clonal selection and adaptive cell states during acquired resistance (2026 · Genome Medicine · 被引 2)
  • A Phase Ib Study of Sapacitabine and Olaparib in Patients with BRCA1/2- Mutated Metastatic Breast Cancer (2025 · Clinical Cancer Research · 被引 1)
  • Cancers modulate processing and presentation of p53 neoantigens to evade T cell detection (2026 · Immunity)